21st European Congress on Alternatives to Animal Testing, September 23-26 2018, University of Linz, Austria

Topics / tentative sessions

(as of 21 December 2017)

Advanced technologies: systems biology, -omics technologies, stem cells

   

3D models & multi-organ-chips (MOC), human-organ-chips (HOC)

   

International progress in 3Rs research - Global cooperation on implementing the 3Rs

   

Replacement – new approaches

   

REACH I – the most frequently used alternatives: "read accross, WoE (Weight of Evidence) & QSAR"

   

REACH II– meeting the 2018 deadline

   

Predictive toxicology & risk assessment  

   

Advanced safety testing of cosmetics and consumer products

   

Specific toxicological endpoints: oral & repeated-dose toxicity, inhalation toxicity, sensitization, reprotox (mEST & hEST), carcinogenesis, nanotoxicology

   

Efficacy and safety testing of drugs and biopharmaceutics including vaccines, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein and living cells used in cell therapy

   

3Rs in medical devices testing

   

Initiative for implementing serum free culture media

   

Disease models using human cells, tissues and organs

   

Biological Barriers

   

Advanced GMO models – CRISPR/cas in vivo & in vitro

   

Ethical and legal issues & Dir 63/2010/EU update

   

Refinement & welfare, culture of care, best practice approaches, avoidance of severe suffering

   

3Rs in education and academia

   

"Young Scientists" session

   

Free communications

   
 
 

Deadlines for your submission of abstracts:

 

- Submission of oral presentations: 31 May 2018
- Submission of posters: 31 May 2018
- Delivery of powerpoint presentations: 14 September 2018

(Please note: The online submission system will be online on 25 January 2018)

Please stay in touchcongress2018@eusaat-congress.eu or subscribe to the newsletter!

If you've any questions, please contact the congress office!